Prevalence of Foot Deformities Among Adolescents in Egyptian Population

May 31, 2026 updated by: Mohammed abdelal farrag abdelmontaleb, Assiut University
The aim of the study is to determine the prevalence of foot deformities among adolescents and associated factors such as age, sex, and pain. This includes identifying the types and degrees of deformities present, assessing their impact on adolescents' health, and examining how these deformities may influence daily activities

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Foot deformities are common musculoskeletal conditions affecting children and adolescents worldwide, with a wide range of causes and clinical presentations. These deformities can result from congenital abnormalities, developmental changes, trauma, neuromuscular disorders, or secondary complications of systemic diseases such as diabetes and rheumatoid arthritis(1,2). Flatfoot, hallux valgus, pes cavus, and clubfoot are among the most frequently encountered types, each with distinct etiologies and clinical features Data will be collected by self-administered structured questionnaire. The aim of the study and the way of filling the questionnaire will be explained in each classroom to the students, and then he fills the questionnaire by himself.

Study Type

Observational

Enrollment (Estimated)

4000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

  • Type of the study This research will be a cross-sectional observational study designed to assess the prevalence and characteristics of foot deformities among adolescents.
  • The study will be conducted in middle and high school student

Description

Inclusion Criteria:

  • Adolescents aged 12-18 years.
  • Willingness to participate and provide informed consent (from both the participant and guardian).
  • Ability to stand and walk without assistance for the physical examination.

Exclusion Criteria:

  • Adolescents with a history of major lower limb surgery or amputation.
  • Those with severe neurological disorders affecting gait or foot structure (e.g., cerebral palsy, spina bifida).
  • Individuals unable to cooperate with the examination due to cognitive or psychiatric disorders.
  • Presence of acute foot trauma or infection at the time of assessment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of foot deformities among adolescents in Egyptian population
Time Frame: Baseline
Prevalence of foot deformities among adolescents, categorized by type (e.g., flatfoot, hallux valgus, pes cavus, clubfoot).
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association between foot deformities and demographic factors (age, sex).
Time Frame: Baseline

Correlation between foot deformities and subjective symptoms (pain, difficulty walking).

Impact of foot deformities on daily activities and quality of life.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2027

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

May 31, 2026

First Submitted That Met QC Criteria

May 31, 2026

First Posted (Actual)

June 4, 2026

Study Record Updates

Last Update Posted (Actual)

June 4, 2026

Last Update Submitted That Met QC Criteria

May 31, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Prevalence of foot deformities

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Foot Deformities

Clinical Trials on Prevalence of foot deformities

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe